Why Is The Best Stock Of The Day NeuroBo Pharmaceuticals Inc. (NRBO)?

Why Is The Best Stock Of The Day NeuroBo Pharmaceuticals Inc. (NRBO)?

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

NeuroBo Pharmaceuticals is a clinical stage biotech firm focusing on disease-modifying therapies for a range of conditions, including viral, neuropathic and/or neurodegenerative diseases. As the firm commercializes these treatments, it provides multi-modal treatments for doctors and medical facilities. 

NeuroBo Pharmaceuticals Inc. NRBO +1.19 (+36.4% Change)

This time last year, NeuroBo Pharmaceuticals traded at twice the price you see today. However, the stock is rebounding, and it has done several times over the past 12 months. 

Why is NRBO Moving?

Pharmaceutical companies with a “low float” are piquing the interest of social media speculators, and NeuroBo Pharma seems to be part of that movement. Buying into the stock at a low price allows investors to get in, wait for the price to rise and get out for a quick profit.

Where to Buy NeuroBo Pharmaceuticals Stock

Choose a broker from this list curated by Benzinga. You need an online brokerage that can help you invest in your future. Feel free to shop around and set up your account with basic personal information and a payment method used to fund your investments.

 

Broker

Best For

Overall Rating

Start Trading

Webull

Intermediate Traders

4.5 Stars

Get Started

Interactive Brokers

Lowest Fees

5 Stars

Get Started

Robinhood

Beginner Traders

4 Stars

Get Started

Moomoo

Active Traders

5 Stars

Get Started

TD Ameritrade

Day Traders

5 Stars

Get Started

 

Stay Ahead of the Game on NRBO

Use Benzinga Pro to make sure you have all the information you need to stay ahead of the game on NRBO. You can build wealth, increase your net worth and invest in companies that make the world a better place—like NeuroBo Pharmaceuticals.

Data for NeuroBo Pharmaceuticals as of July 20, 2021

Summary of NeuroBo Pharmaceuticals as of July 20, 2021:

  • Price Change: $2.820 to $3.845
  • 52 Week Low: $2.7
  • 52 Week High: $9.0399
  • Market Cap: $62.845M
  • P/E Ratio: -
  • Dividend Yield: -

Significant Dates for NeuroBo Pharmaceuticals:

  • Next Earnings Date: August 10, 2021
  • Last Earnings Date: May 7, 2021, EPS of $-0.150
  • Ex-Dividend Date: -
  • Dividend Payment Date: -

Technical Data of NeuroBo Pharmaceuticals as of July 20, 2021:

  • RSI: 70.9970 ⮕ Bullish
  • MACD: Signal Line (0.0516) Over MACD (-0.0501) ⮕ Bullish
  • Bollinger Bands: Price ($3.845), 20-Day SMA ($2.98), Lower Band ($2.6833), Upper Band ($3.3867) ⮕ Bullish

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.

Posted In: Penny StocksMarkets